19
May

Marker Identifies Breast Cancer Patients Likely to Respond to Tamoxifen

ER positive breast cancer patients whose tumors have active protein Stat5 have increased likelihood of responding to anti-estrogen therapy PHILADELPHIA—Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy. The research appears …

11
May

Dr. Neal Flomenberg, Half-Match Transplant Procedure Featured in JNCI

Neal Flomenberg, M.D., chair of medical oncology at Jefferson, and Dolores Grosso, RN, CRNP, were featured in a news article on haploidentical bone marrow transplants in the Journal of the National Cancer Institute titled, “Half-Match Bone Marrow Transplants May Raise Odds for More Recipients.” Dr. Flomenberg and Dolores Grosso devised a two-step, half-match procedure that …

6
May

May is National Cancer Research Month

The Kimmel Cancer Center at Jefferson is joining the American Association for Cancer Research to celebrate the month of May as National Cancer Research Month. KCC—a National Cancer Institute (NCI) designated cancer center—is home to internationally renowned cancer physicians and research scientists. Our world-renowned research faculty is discovering cancer risk factors, designing effective prevention strategies, …

6
May

KCC American Cancer Society Research Symposium

The 3rd Annual Kimmel Cancer Center American Cancer Society Research Symposium will be held today at 2 p.m. in 101 BLSB. KCC Director Richard Pestell, M.D, Ph.D, will present the keynote address and 2010 American Cancer Society-Institutional Research Grant Award recipients. Amy Leader, DrPH, MPH, and Hushan Yang, Ph.D, will discuss their research. A reception …

26
Apr

KCC Team to Walk for Bladder Cancer

It is estimated that more than 70,000 new cases of bladder cancer were diagnosed in 2010, making it the 5th most commonly diagnosed cancer in the U.S. Please join Dr. Jean Hoffman-Censits, of the Department of Medical Oncology, Solid Tumor Division, and the Kimmel Cancer Center at Jefferson Team in raising awareness of the disease …

19
Apr

Dr. Edith Mitchell attends National Summit on Health Disparities, Hon. Nancy Pelosi and Sen. Harry Reid honored

Edith Mitchell, M.D., clinical professor of Medicine and Medical Oncology at Jefferson Medical College of Thomas Jefferson University, attended the 8th Annual National Summit on Health Disparities Meeting & Awards Dinner in Washington, D.C., on April 11 and 12. The summit, organized by The National Minority Quality Forum and the Congressional Black Caucus Foundation, in …

19
Apr

Jefferson Researchers Unlock Key to Personalized Cancer Medicine Using Tumor Metabolism

Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any …

14
Apr

Laura Doyle to speak at American Brachytherapy Society Annual Meeting

Several researchers from Thomas Jefferson University’s Department of Radiation Oncology will participate in this year’s American Brachytherapy Society Annual Meeting in San Diego, Calif. Laura Doyle, M.S., a medical physicist at the Bodine Center for Cancer Treatment, will be moderating a session called “Clinical Advancements in Microbrachytherapy” on Friday, April 15 from 4:30 to 5:00 …

13
Apr

Jefferson Doctors Strengthen Case for High-Dose Radiotherapy Technique After Radical Prostatectomy

A widely-available yet expensive radiotherapy technique used to treat prostate cancer patients after surgery has promising benefits—higher dose and less damage to the rectum and bladder—compared to a less precise technique, Thomas Jefferson University researchers document for the first time in a new study published in Practical Radiation Oncology. A team of radiation oncologists and …

7
Apr

Celebrating National Cancer Registrars Week

Cancer Registrars throughout the United States and abroad will join their colleagues, community leaders, and other medical professionals to observe the 15th annual National Cancer Registrars Week, April 11th-15th. Quality cancer data is central to the nation’s fight against cancer, and cancer registrars are the first link in capturing these data. Our Cancer Registry works …

6
Apr

Kimmel Cancer Center at Jefferson breast cancer symposium features latest in research, treatment

The latest advances in both breast cancer treatment and research – including innovations in diagnostic, surgical, chemotherapy and radiation approaches – will be discussed Friday, April 8, 2011, at a breast cancer symposium at the Kimmel Cancer Center at Jefferson in Philadelphia. The all-day, breast cancer symposium, part of an annual series at the Kimmel …

1
Apr

Kimmel Cancer Center “All Hands” Meeting

The Kimmel Cancer Center held it’s quarterly “All Hands” meeting on March 29, 2011. Dr. Richard Pestell, Director of the Kimmel Cancer Center, delivered his quarterly “State of the Cancer Center” address. Awards were presented in four  categories. The Nursing Award was presented to Carole Muto, RN, MSN, CPAN. The Clinical Award was presented to …

1
Apr

Get Healthy Philadelphia Tobacco Policy and Control Speaker Series

On March 25th, the Jefferson School of Population Health and Philadelphia Department of Health hosted a seminar featuring Rosemarie Henson, MSSW, MPH. Ms. Henson is the Senior Advisor to the Assistant Secretary for Health at the Department of Health and Human Service (DHHS). Prior to her position at DHHS, Ms. Henson directed multiple disease prevention …

29
Mar

NCI Highlights Recent Discovery By Dr. Lisanti

The work of Michael P. Lisanti, Professor and Chair of Stem Cell Biology and Regenerative Medicine & Leader of the KCC Molecular  Biology & Genetics Program was recently highlighted on the NCI’s Physical Sciences-Oncology Centers Research News Website in an article entitled “Tumors Acts As Parasites, Sucking Energy From Surrounding Cells “  (article link). The …

22
Mar

Jefferson Clinical Trial: Can a Cholesterol Drug Prevent Colon Cancer?

Thomas Jefferson University has started recruiting patients for a new National Cancer Institute (NCI)-sponsored clinical trial to test whether the cholesterol-reducing drug rosuvastatin is effective in the prevention of recurrent colon cancer. Previous laboratory research and population studies have shown that patients taking statins, the class of drugs that lowers cholesterol, had fewer colon polyps, …

10
Mar

Jefferson Researchers Unravel Protein’s Elusive Role in Embryo and Disease Development in Nature

Reporting in Nature, scientists from Thomas Jefferson University have determined that a single protein called FADD controls multiple cell death pathways, a discovery that could lead to better, more targeted autoimmune disease and cancer drugs. Twelve years ago, internationally-known immunologistan associate professor in the Department of Microbiology and Immunology at Thomas Jefferson University, realized FADD, …

Page 1 of 19